Thyroxine

Thyroxine

SCHEMBL4575383

NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O.NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

THRATHRB

The experimentally established mechanism targets of Thyroxine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB known ✓ P10828 11/20 1.00
THRA known ✓ P10827 7/20 1.00
MEN1 O00255 7/20 1.00
KMT2A Q03164 7/20 1.00
LMNA P02545 5/20 1.00
PPARG P37231 5/20 1.00
HSD17B10 Q99714 3/20 1.00
USP2 O75604 3/20 1.00
TTR P02766 2/20 1.00
ADORA3 P0DMS8 2/20 1.00
PDE4D Q08499 2/20 1.00
NR1I2 O75469 2/20 1.00
RXRA P19793 2/20 1.00
ALDH1A1 P00352 2/20 1.00
MAPT P10636 2/20 1.00
NR3C1 P04150 1/20 1.00
CYP1A2 P05177 1/20 1.00
HTR1A P08908 1/20 1.00
CYP2C9 P11712 1/20 1.00
TBXA2R P21731 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dextrothyroxine SCHEMBL30885760 1.00 THRB (1.00) THRBMEN1KMT2ATHRALMNA
Thyroxine SCHEMBL11131863 1.00 THRB (1.00) THRBMEN1KMT2ATHRALMNA
Levothyroxine SCHEMBL3286699 1.00 THRB (1.00) THRBMEN1KMT2ATHRALMNA
Dextrothyroxine SCHEMBL61194 1.00 THRB (1.00) THRBMEN1KMT2ATHRALMNA
Thyroxine SCHEMBL26147 1.00 THRB (1.00) THRBMEN1KMT2ATHRALMNA
Levothyroxine SCHEMBL4997979 1.00 THRB (1.00) THRBMEN1KMT2ATHRALMNA
Thyroxine SCHEMBL7944262 1.00 THRB (1.00) THRBMEN1KMT2ATHRALMNA
Levothyroxine SCHEMBL23098 1.00 THRB (1.00) THRBMEN1KMT2ATHRALMNA
Thyroxine SCHEMBL11320096 0.99 THRB (0.97) THRBMEN1KMT2ATHRALMNA
Thyroxine SCHEMBL2014581 0.99 THRB (0.97) THRBMEN1KMT2ATHRALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101023349-B Biomarker for ovarian cancer 约翰·霍普金斯大学 2016-11-02 CN claimed
CN-110338843-A Tissue-estimating method, apparatus, equipment and computer readable storage medium 无锡海斯凯尔医学技术有限公司 2019-10-18 CN disclosed
CN-107655878-B For detecting the micro-fluidic chemiluminescence detection system of the magnetic particle of thyroid function 北京华科泰生物技术股份有限公司 2019-03-15 CN disclosed
CN-103889407-A Novel therapies for transthyretin-associated amyloidosis SOM INNOVATION BIOTECH S L 2014-06-25 CN disclosed
CN-101897700-A Compositions and method with non-naturally occurring prostaglandins treatment alopecia PROCTER & GAMBLE 2010-12-01 CN disclosed
CN-101229171-A Compositions and methods for treating hair loss using non-naturally occurring prostaglandins UNIV DUKE (US) 2008-07-30 CN disclosed
WO-2008088343-A1 METHODS FOR INDIVIDUALIZED HEALTH ASSESSMENT SERVICE BIOPHYSICAL CORPORATION (US) 2008-07-24 WO disclosed
CN-100384425-C Compositions and methods for treating hair loss using non-natural prostaglandins PROCTER & GAMBLE (US) 2008-04-30 CN disclosed
CN-1221238-C Compositions and methods for treating hair loss using oximyl-and hydroxylamino-prostaglandins PROCTER & GAMBLE (US) 2005-10-05 CN disclosed
US-20050159352-A1 Use of monocarboxylate transporter protein for thyroid hormone transport STICHTING TOT BEVORDERING VAN DE WETENSCHAP DER ENDOCRINOLOGIE (NL) 2005-07-21 US disclosed
WO-2003099864-A1 USE OF MONOCARBOXYLATE TRANSPORTER PROTEIN FOR THYROID HORMONE TRANSPORT STICHTING TOT BEVORDERING VAN DE WETENSCHAP DER ENDOCRINOLOGIE (NL) 2003-12-04 WO disclosed
CN-1419437-A Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins PROCTER & GAMBLE (US) 2003-05-21 CN disclosed
CN-1419439-A Compositions and methods for treating hair loss using oximino-and hydroxylamino-prostaglandins PROCTER & GAMBLE (US) 2003-05-21 CN disclosed
CN-1419438-A Compositions and methods for treating hair loss using 2-decarboxylated-2-phosphosubunit derivatives PROCTER & GAMBLE (US) 2003-05-21 CN disclosed
WO-1997017951-A1 STABILIZED THYROID HORMONE PREPARATIONS AND METHODS OF MAKING SAME KNOLL PHARMACEUTICAL COMPANY (US) 1997-05-22 WO disclosed
WO-1993017335-A1 BRIDGE IMMUNOASSAY TRITON DIAGNOSTICS, INC. (US) 1993-09-02 WO disclosed
US-4812396-A REFRACTIVE PARTICLES WITH LIGAND COATING E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-03-14 US disclosed
US-4812395-A REFRACTIVE PARTICLES WITH LIGAND COATING E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-03-14 US disclosed
US-4399121-A Iodothyronine immunogens and antibodies MILES LABORATORIES, INC. (US) 1983-08-16 US disclosed
US-4358604-A ANTIBODIES-USEFUL IN IMMUNOASSAY MILES LABORATORIES, INC. (US) 1982-11-09 US disclosed